Bevacizumab in Combination With Temozolomide in Patients With Neuroendocrine Tumors

Clinical trial NCT00137774 · COMPLETED

Trial details

NCT number: NCT00137774
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neuroendocrine Tumors

Start date: 2004-11-01
Primary completion: 2005-07-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.